IFNA2 and COVID-19: Gonçalves et al. (2021) observed a 25% positivity rate in critical COVID-19 patients using ELISA, while only 18% exhibited neutralizing activity through the luciferase reporter assay at a concentration of 10 ng/mL of IFN-α2 or IFN-ω (24).